Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2003
04/08/2003US6544548 Hydratable keratin solid which forms a hydrogel upon addition of water for use in nonwoven films, diapers, skin treatments, prosthetic devices, excipients, tissue engineering scaffolds; controlled drug delivery
04/08/2003US6544546 Ring-shaped devices
04/08/2003US6544544 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule
04/08/2003US6544543 Depositing layer of polymer on luminal surface of target vessel; injecting microspheres containing vasoconstrictor into patient, wherein microspheres are adapted to attach to layer of polymer and release vasoconstrictor in situ
04/08/2003US6544542 For the administration of a drug which is sparingly soluble in water
04/08/2003US6544541 Devices and compounds for treating arterial restenosis
04/08/2003US6544539 Composition and method for producing lubricating, germicide foam
04/08/2003US6544535 Composition for improving cooling sensation effects
04/08/2003US6544533 10-hydroxy-2-decenoic acid compounds for promoting desquamation/epidermal renewal of the skin and/or combating skin aging
04/08/2003US6544530 Stable oil-in-glycerin emulsion
04/08/2003US6544510 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
04/08/2003US6544509 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
04/08/2003US6544508 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799)
04/08/2003US6544502 Skin treatment with a water soluble antibiotic dissolved in an electrolyzed water
04/08/2003US6544497 Modulated release particles for aerosol delivery
04/08/2003US6544290 Cell seeding of ceramic compositions
04/08/2003US6544252 Osmotic delivery system having space efficient piston
04/08/2003US6544083 Shift mechanism for a marine propulsion system
04/08/2003US6543632 Feeder bottles
04/08/2003CA2333701C .alpha.-hydroxy fatty acid derivatives and external compositions containing the same
04/08/2003CA2232583C Lipoic acid in topical compositions
04/08/2003CA2191344C Synthetic peptide analogs of lung surfactant protein sp-c
04/08/2003CA2175471C Sucrose distearate lipid vesicles
04/08/2003CA2074322C A composition for the sustained and controlled release of medicamentous substances and a process for preparing the same
04/08/2003CA2071623C Cyclodextrin composition
04/08/2003CA2023810C Pharmaceutical composition
04/04/2003WO2002030436A1 Method for producing phyllanthus extracts
04/04/2003WO2002030390A2 Method for producing powdery formulations
04/04/2003CA2424930A1 Method for producing phyllanthus extracts
04/03/2003WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
04/03/2003WO2003027169A1 Material consisting of at least a biodegradable polymer and cyclodextrins
04/03/2003WO2003027118A1 Pharmaceutically acceptable salts of 20(s)-camptothecins
04/03/2003WO2003026806A1 Device for production of a pharmaceutical film
04/03/2003WO2003026767A2 Lysin-deficient bacteriophages having reduced immunogenicity
04/03/2003WO2003026743A2 Opioid formulations having reduced potential for abuse
04/03/2003WO2003026733A2 Microneedle with membrane
04/03/2003WO2003026717A1 Nitric oxide-releasing coated medical devices and method of preparing same
04/03/2003WO2003026697A2 Organoleptically acceptable intraorally disintegrating compositions
04/03/2003WO2003026687A1 Delivery system for biological component
04/03/2003WO2003026680A2 Method and topical formulation for treating skin conditions associated with aging
04/03/2003WO2003026671A1 Method of treating middle ear infections
04/03/2003WO2003026669A1 Monobactam antibacterial compounds and methods of use thereof
04/03/2003WO2003026659A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/03/2003WO2003026656A1 New formulations and use thereof
04/03/2003WO2003026655A1 New formulations and use thereof
04/03/2003WO2003026654A1 Nicotine-containing film preparation
04/03/2003WO2003026642A1 Freeze-dried pharmaceutical preparation
04/03/2003WO2003026637A2 Dosage form for treatment of diabetes mellitus
04/03/2003WO2003026631A1 Delivery of drug esters through an inhalation route
04/03/2003WO2003026630A1 Dosage forms having an inner core and outer shell with different shapes
04/03/2003WO2003026629A2 Modified release dosage forms
04/03/2003WO2003026628A2 Composite dosage forms having an inlaid portion
04/03/2003WO2003026627A1 Composite dosage forms
04/03/2003WO2003026626A2 Modified release dosage forms
04/03/2003WO2003026625A1 Modified release dosage forms
04/03/2003WO2003026624A1 Modified release dosage forms
04/03/2003WO2003026623A1 Intraorally disintegrating valdecoxib compositions
04/03/2003WO2003026622A1 Lisinopril compositions having large-particle dcpd
04/03/2003WO2003026621A2 Method for making an oral pharmaceutical product with tell-tale agents, in particular of taste and resulting product
04/03/2003WO2003026620A1 Method for producing tablets from plant extracts
04/03/2003WO2003026619A1 Granules having improved dosing properties
04/03/2003WO2003026618A1 Localized non-invasive biological modulation system
04/03/2003WO2003026617A2 (ester)-lysolecithins in liposomes
04/03/2003WO2003026616A1 Edible composition and dosage form comprising an edible shell
04/03/2003WO2003026615A2 Modified release dosage forms
04/03/2003WO2003026614A1 Dosage form containing a confectionery composition
04/03/2003WO2003026613A1 Fondant-based pharmaceutical composition
04/03/2003WO2003026612A2 Dosage forms having an inner core and outer shell
04/03/2003WO2003026611A2 Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
04/03/2003WO2003026610A2 Process for the preparation of fast dissolving dosage form
04/03/2003WO2003026594A2 Use of microcapsules containing ginger oil
04/03/2003WO2003026589A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
04/03/2003WO2003026588A2 Methods and apparatus for extrusion of vesicles at high pressure
04/03/2003WO2003026581A2 Pharmaceutical compositions and methods for treating cancer
04/03/2003WO2003026560A1 Multi-cored molded article, method of producing the same, and device for producing the same
04/03/2003WO2003026555A2 Floating osmotic device for controlled release drug delivery
04/03/2003WO2003026492A2 Prevention and treatment of restenosis by local administration of drug
04/03/2003WO2003026439A1 A starch-based delivery system for creatine
04/03/2003WO2003026438A1 A carbohydrate-based delivery system for creatine and other bioactive ingredients
04/03/2003WO2003026420A1 Bactericidal solutions
04/03/2003WO2003013478A8 Method of encapsulating an active substance
04/03/2003WO2002102331A3 Substrates utilizing shear responsive micropockets for storage and delivery of substances
04/03/2003WO2002102305A3 Adjuvant composition for mucosal and injection delivered vaccines
04/03/2003WO2002100418B1 Exothermic formulations for the treatment of ectoparasites
04/03/2003WO2002100346A3 (r, r'),(r',s')-amphetaminil, compositions and uses thereof
04/03/2003WO2002094172A3 Compartmentalized dosage form
04/03/2003WO2002092049A3 System for delivering cosmetics and pharmaceuticals
04/03/2003WO2002089849B1 Compositions and delivery systems for administration of a local anesthetic agent
04/03/2003WO2002085338A3 Ipratropium formulation for pulmonary inhalation
04/03/2003WO2002085296A3 Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
04/03/2003WO2002062352A3 Devices and methods for management of bone density
04/03/2003WO2002060524A3 Enhanced ultrasound detection with temperature dependent contrast agents
04/03/2003WO2002045713A3 Orally-bioavailable formulations of fentanyl and congeners thereof
04/03/2003WO2002030400A1 Solid preparations
04/03/2003WO2002022174A9 A novel cationic lipopolymer as biocompatible gene delivery agent
04/03/2003WO2002012524A3 Adenovirus e1b-55k single amino acid mutants and methods of use
04/03/2003WO2002011703A9 Hybrid neuroprosthesis for the treatment of brain disorders
04/03/2003WO2002011698A9 Novel compositions of minoxidil
04/03/2003WO2001091723A3 Fluorinated copolymer surfactants and use thereof in aerosol compositions
04/03/2003US20030066096 Comprises encapsulated green fluorescent protein, blue fluorescent protein, and/or phycobiliprotein; for use in toys, paints, slimy play material, textiles (clothing), bubbles, ballons, cosmetics, bath powders, lotions, and foods
1 ... 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 ... 2991